Compounds > tris(2-carboxyethyl)phosphine
Page last updated: 2024-09-03

tris(2-carboxyethyl)phosphine and Benign Neoplasms

tris(2-carboxyethyl)phosphine has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busch, M; Gianolio, DA; Hou, L; Park, A; Stefano, JE1

Other Studies

1 other study(ies) available for tris(2-carboxyethyl)phosphine and Benign Neoplasms

ArticleYear
Micro- and mid-scale maleimide-based conjugation of cytotoxic drugs to antibody hinge region thiols for tumor targeting.
    Methods in molecular biology (Clifton, N.J.), 2013, Volume: 1045

    Topics: Antineoplastic Agents; Immunoconjugates; Maleimides; Molecular Targeted Therapy; Neoplasms; Phosphines; Pilot Projects; Polyethylene Glycols; Reducing Agents; Sulfhydryl Compounds

2013